Welcome to our dedicated page for Hologic news (Ticker: HOLX), a resource for investors and traders seeking the latest updates and insights on Hologic stock.
Hologic Inc. (NASDAQ: HOLX) is a leading global healthcare company dedicated to the science of sure. Headquartered in Bedford, Massachusetts, Hologic specializes in developing, marketing, and servicing some of the most innovative and accurate diagnostic imaging systems and surgical products available today. The company's core business focuses on meeting the healthcare needs of women, operating through five primary segments: diagnostics, breast health, surgical, and skeletal health.
Diagnostics, which accounts for 60% of total sales, has seen a significant boost due to the pandemic, underscoring the company's strategic pivot toward commercial diagnostics following the acquisition of Gen-Probe. This segment includes a wide range of tests and instruments essential for early disease detection and management.
Breast Health, traditionally a cornerstone of Hologic’s business, contributes 14% to total sales. Though this segment was initially suppressed by the pandemic, it remains vital for innovations in mammography and breast surgery. Hologic's Surgical segment, representing 11% of sales, offers advanced products that enhance surgical outcomes and patient safety. The Skeletal Health segment, although smaller at 1% of total sales, provides critical tools for assessing bone health.
Hologic’s reach is vast, with the United States accounting for 69% of its revenue, followed by Europe at 20%, Asia at 8%, and other international markets making up the remaining 3%. The company's diverse, dedicated, and creative team is committed to not only advancing medical science but also providing greater confidence and peace of mind in diagnosis, enabling healthier lives worldwide.
Stay updated with the latest from Hologic by connecting on Hologic.com, Facebook, and Twitter.
Hologic has partnered with the WTA to enhance women’s health and wellness through advanced screening technologies, starting at the BNP Paribas Open in Indian Wells. The collaboration includes providing athletes with access to Hologic’s Horizon® DXA system for detailed body composition and bone health analysis. Alongside enhanced screenings, Hologic will support the ACEing Cancer program, aimed at raising awareness and funds for women’s cancers. This partnership aims to prioritize women's health and addresses the decline in health screenings due to the COVID pandemic.
Hologic has announced a landmark multi-year partnership with the WTA, becoming the official health partner and global title sponsor of the WTA Tour. This represents the largest global sponsorship in WTA history and marks Hologic’s first worldwide sponsorship. The collaboration aims to promote women’s health and equality through initiatives that emphasize preventive care and healthy living. Hologic, known for its innovations in women’s health, will also support the creation of Hologic WTA Labs, focusing on health innovation for female athletes.
Hologic, Inc. (Nasdaq: HOLX) has announced its upcoming participation in two significant investor conferences. The first is Citi's 2022 Healthcare Services, Medtech, Tools & HCIT Virtual Conference scheduled for February 23 at 1:15 p.m. ET. The second is The Raymond James Institutional Investors Conference on March 8 at 9:50 a.m. ET. Both presentations will be webcast live and available for 30 days on Hologic's investor website.
Hologic focuses on enhancing women's health through early detection and treatment solutions.
Hologic (HOLX) reported Q1 2022 revenue of $1.471 billion, down 8.6% year-over-year, notably exceeding prior guidance of $1.1-$1.15 billion. GAAP diluted EPS was $1.95 while non-GAAP diluted EPS was $2.17, both below last year's figures. Organic revenue grew 9% excluding COVID sales, with Breast Health and GYN Surgical divisions each above 8% growth. The company significantly raised its full-year revenue guidance by $600 million and non-GAAP EPS by $1.35. Cash flow from operations remained robust at $564.2 million.
Hologic (Nasdaq: HOLX) has unveiled its first national direct-to-consumer advertising campaign, launching during the 'Big Game' on NBC on February 13, 2022. The campaign, titled "Her Health is Her Wealth", features Mary J. Blige and aims to promote preventive screenings for women, emphasizing the importance of regular health check-ups that many missed during the COVID-19 pandemic. Research indicates that nearly 50% of women aged 16-54 have not had a health screening in the past year. The campaign will also include digital activations via ScreeningsForHer.com.
Hologic, Inc. (NASDAQ: HOLX) reported preliminary revenue of
Hologic, Inc. (NASDAQ: HOLX) will release its financial results for Q1 Fiscal 2022 on February 2, 2022, after market close. Management will host a conference call at 4:30 p.m. ET the same day. Interested participants can join by dialing specified numbers or via a live webcast on the company's website. A replay will be available until February 25, 2022. Hologic is dedicated to enhancing women's health through innovative medical technology solutions.
Hologic, Inc. (NASDAQ: HOLX) has expanded its Global Access Initiative (GAI) to include the Aptima® SARS-CoV-2 assay, aimed at improving access to COVID-19 diagnostics in resource-limited countries. The GAI, launched in 2018, facilitates affordable diagnostic testing without upfront costs. Hologic has already provided over 700,000 SARS-CoV-2 tests during the pandemic, partnered with organizations like WHO and UNICEF. This expansion enhances accessibility and reflects Hologic's commitment to equitable health systems worldwide.
Hologic, Inc. (NASDAQ: HOLX) will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 1:30 p.m. Eastern Time. The presentation and Q&A session will be webcast live and accessible through Hologic’s investor website. The webcast will remain available for 30 days post-event. Hologic focuses on enhancing women's health through early detection and treatment technologies. For further details, visit www.hologic.com.
FAQ
What is the current stock price of Hologic (HOLX)?
What is the market cap of Hologic (HOLX)?
What does Hologic Inc. specialize in?
Where is Hologic Inc. headquartered?
What are the main segments of Hologic’s business?
Which segment contributes the most to Hologic's revenue?
How has the pandemic affected Hologic’s business segments?
What percentage of Hologic’s revenue comes from the United States?
How did the acquisition of Gen-Probe impact Hologic?
How can I stay updated with Hologic's latest news?
What is Hologic’s approach to healthcare?
What percentage of Hologic’s revenue comes from international markets?
